Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

192,841-192,900 of 319,975

filter-aware
01
Slide 1
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
02
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
03
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
04
The slide uses a side-by-side comparison framework to highlight two major therapeutic areas.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style visualization to show the progress of different drug candidates.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
06
Features a scientist standing in front of a whiteboard with diagrams.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
07
The slide uses a mix of epidemiological data and commercial benchmarks to validate the market size.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Market Size1 hit
08
Uses a biological analogy (brake pedal) to explain gene function.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide uses a hub-and-spoke diagram to illustrate the three core pillars of the platform.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a process flow diagram to explain the therapeutic mechanism of action.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses a 2x2 matrix structure to compare two patients across two time points.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Solution1 hit
12
The slide uses a visual process flow to explain the mechanism of action for a biotech product.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Solution1 hit
13
Includes PET scan imagery showing metabolic response in a patient.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
14
The table displays patient-level outcomes including response type, prior therapy history, and number of prior lines of therapy.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
15
Data presented at AACR 2021. Shows two separate mouse model experiments (H1975-OsiR and H1975).Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
16
The slide outlines a two-phase clinical trial structure and the specific patient progression timeline being measured.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
17
The slide outlines the clinical trial methodology for a drug combination study.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a Kaplan-Meier survival plot to illustrate therapeutic efficacy.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
19
The slide uses bioluminescence imaging and bar charts to show immune cell activation (T cells, NK cells, MDSC, DC) in response to treatment.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
20
The slide presents two charts: a line chart showing tumor progression over time and a bar chart showing tumor intensity at week 4.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
21
The slide outlines a clinical trial methodology for a Phase 1/2 study.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
22
Clinical trial design summary for REQORSA combination therapy.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
23
The slide uses a histology image to visually demonstrate negative TUSC2 expression in SCLC.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
24
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
25
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
26
The slide uses a pie chart to illustrate the market split between Type 1 and Type 2 diabetes.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
27
The slide uses a two-column layout to contrast disease burden metrics with market size projections.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
28
The slide uses a two-column layout to present various medical conditions caused by diabetes, supported by statistical data points.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
29
Includes a scientific diagram illustrating the alpha-to-beta cell reprogramming process.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
30
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
31
The slide lists four key executives with their titles and professional highlights.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team1 hit
32
The slide highlights key leadership roles in IP, manufacturing, HR, and regulatory affairs.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team1 hit
33
The slide specifically highlights the Scientific Advisory Board rather than the executive management team.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team1 hit
34
The slide specifically highlights the Clinical Advisory Board rather than the executive management team.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team1 hit
35
The slide lists five individuals with their titles and professional backgrounds.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Team1 hit
36
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
37
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Loop · Why Now1 hit
38
The slide uses a split-screen layout with a blue left panel for the vision statement and a white right panel for key strategic pillars.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Loop · Why Now1 hit
39
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
31
The slide presents a Glucose Tolerance Test line chart and a bar chart for beta cell mass, demonstrating the efficacy of the AAV8-PM gene therapy.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
32
Includes a line chart showing blood glucose over time and a bar chart showing beta cell mass comparison.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
33
The charts track insulin/carb ratios over time relative to a viral infusion event.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
34
Includes a microscopic image of cells.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
35
Genprex | Investor Presentation Deck | 44 slidesGenprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
36
Genprex | Investor Presentation Deck | 44 slidesGenprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action1 hit
37
The slide highlights the company management team with headshots and bulleted professional summaries.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action1 hit
38
The slide specifically highlights the Scientific Advisory Board rather than the core management team.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action1 hit
39
The slide specifically highlights the Clinical Advisory Board rather than the executive management team.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action1 hit
40
The slide lists 5 individuals, one of whom has a placeholder for a photo.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action1 hit
41
Genprex | Investor Presentation Deck | 44 slidesGenprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action1 hit
42
The slide uses a two-column layout to contrast past progress with future goals.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Action1 hit
43
The slide uses a split-screen layout to contrast the high-level vision (left) with specific strategic pillars (right).Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
44
Genprex | Investor Presentation Deck | 44 slidesGenprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
01
Slide 1
The slide features a branded moss wall with the company logo.Guaranty Bancshares | Results Presentation Deck | 12 slides · Guaranty Bancshares
Conference presentation Investor relations 1 hit
02
Guaranty Bancshares | Results Presentation Deck | 12 slidesGuaranty Bancshares | Results Presentation Deck | 12 slides · Guaranty Bancshares
Conference presentation Investor relations 1 hit
03
Guaranty Bancshares | Results Presentation Deck | 12 slidesGuaranty Bancshares | Results Presentation Deck | 12 slides · Guaranty Bancshares
Conference presentation Investor relations 1 hit
04
Guaranty Bancshares | Results Presentation Deck | 12 slidesGuaranty Bancshares | Results Presentation Deck | 12 slides · Guaranty Bancshares
Conference presentation Investor relations 1 hit
05
The slide uses a structured layout with three thematic categories on the left and corresponding bulleted data points on the right.Guaranty Bancshares | Results Presentation Deck | 12 slides · Guaranty Bancshares
Conference presentation Investor relations 1 hit
06
Guaranty Bancshares | Results Presentation Deck | 12 slidesGuaranty Bancshares | Results Presentation Deck | 12 slides · Guaranty Bancshares
Conference presentation Investor relations 1 hit
07
The slide outlines financial projections and risk management strategies for the upcoming fiscal year.Guaranty Bancshares | Results Presentation Deck | 12 slides · Guaranty Bancshares
Conference presentation Investor relations 1 hit